BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dietrich CG, Rau M, Geier A. Screening for nonalcoholic fatty liver disease-when, who and how? World J Gastroenterol 2021; 27(35): 5803-5821 [PMID: 34629804 DOI: 10.3748/wjg.v27.i35.5803]
URL: https://www.wjgnet.com/1007-9327/full/v27/i35/5803.htm
Number Citing Articles
1
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver DisorderCurrent Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
2
Chun-Yi Wang, Hsiang-Han Kao, Kuan-Yu Lai, Ching-Chun Lin, Wen-Yuan Lin, Chiu-Shong Liu, Tsung-Po Chen. Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional StudyMetabolites 2022; 12(10): 893 doi: 10.3390/metabo12100893
3
Pei Chia Eng, Roberta Forlano, Tricia Tan, Pinelopi Manousou, Waljit S. Dhillo, Chioma Izzi-Engbeaya. Non-alcoholic fatty liver disease in women – Current knowledge and emerging conceptsJHEP Reports 2023; 5(10): 100835 doi: 10.1016/j.jhepr.2023.100835
4
Marilena Anastasaki, Sophia Papadakis, Irini N. Gergianaki, Loucas Papastamatiou, Eftychios Aligizakis, Nikoleta Grillaki, Eleni Boutzoukaki, Nektarios Sivaropoulos, Foteini Anastasiou, Juan Mendive, Carlos de Juan-Asenjo, Rosario Hernández-Ibáñez, Alba Martínez-Escudé, Montserrat Garcia-Retortillo, Ger Koek, Leen Heyens, Jean Muris, Christos D. Lionis. Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in EuropeFrontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1383112
5
Ayoub Basham, Shideh Rafati, Saeed Hosseini Teshnizi, Ebrahim Evazi, Fereshteh Khozeimeh, Seyed Moayed Alavian, Farkhondeh Razmpour. Application of the Chinese Visceral Adiposity Index in the Diagnosis of Hepatic Steatosis and Liver Fibrosis: A Cross-Sectional StudyHepatitis Monthly 2024; 23(1) doi: 10.5812/hepatmon-150455
6
Michelle J Allen, Rachael Doran, David Brain, Elizabeth E Powell, James O’Beirne, Patricia C Valery, Adrian Barnett, Ruvini Hettiarachchi, Ingrid J Hickman, Sanjeewa Kularatna. A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levelsBMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09934-2
7
Mohamed El-Kassas, Heba A. Othman, Mohamed Elbadry, Khalid Alswat, Yusuf Yilmaz. Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular CarcinomaJournal of Clinical and Experimental Hepatology 2025; 15(1): 102415 doi: 10.1016/j.jceh.2024.102415
8
Neues zur Fettleber: Nomenklatur, Screening-Empfehlungen, Therapiebemühungen und andere klinisch relevante AspekteZeitschrift für Gastroenterologie 2023; 61(10): 1419 doi: 10.1055/a-2149-7976
9
Michael H. Storandt, Sri Harsha Tella, Mikolaj A. Wieczorek, David Hodge, Julia K. Elrod, Philip S. Rosenberg, Zhaohui Jin, Amit Mahipal. Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United StatesCancers 2024; 16(4): 684 doi: 10.3390/cancers16040684
10
Barbara Janota, Elżbieta Szczepańska, Brygida Adamek, Ewa Janczewska. Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?World Journal of Hepatology 2023; 15(5): 641-648 doi: 10.4254/wjh.v15.i5.641
11
Mohamed El-Kassas, Abeer Awad, Mohamed Elbadry, Juan Pablo Arab. Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseSeminars in Liver Disease 2024; 44(01): 054 doi: 10.1055/a-2253-9181
12
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
13
Laura De Rosa, Gabriele Ricco, Maurizia Rossana Brunetto, Ferruccio Bonino, Francesco Faita. Sustainability of General Population Screening for Steatotic Liver Disease: A Proof-of-Concept StudyHealthcare 2025; 13(7): 759 doi: 10.3390/healthcare13070759
14
Svetlana V. Turkina, Mikhail E. Statsenko, Irina A. Tyshchenko, Marina N. Titarenko, Marina A. Kosivtsova, Elena E. Gorbacheva. Cardio-metabolic disorders in a patient with non-alcoholic fatty liver disease and normal body weightJournal of Volgograd State Medical University 2024; 21(3): 109 doi: 10.19163/1994-9480-2024-21-3-109-117
15
Markos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, Stephanos Vassilopoulos, Ingrid Lazaridou, Eleftherios Mylonakis, Kittichai Promrat, Jack R. Wands. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2023; 21(7): 1708 doi: 10.1016/j.cgh.2023.01.001
16
Ali Kirik, Hilmi Erdem Sumbul, Nizameddin Koca, Türkan Paşalı Kilit, Sibel Demiral Sezer, Emine Binnetoglu, Eşref Araç, İhsan Solmaz, Hacer Şen, İbrahim Demirci, Bahri Abaylı, Hale Akan, Canan Akkuş, Berrin Aksakal, Gulali Aktas, Ömer Faruk Alakuş, Burçin Meryem Atak Tel, Ahmet Aydın, Sami Bahçebaşı, Orhan Balıkçı, Lale Saka Baraz, Bilgin Bahadır Başgöz, Muharrem Bayrak, Hilal Bektaş Uysal, Hatice Beyazal Polat, İfakat İrem Biçer, Rıfat Bozkuş, Fatih Coşkun, Cüneyt Çağatay, Feride Çağlar, Erkan Çakmak, Deniz Cekiç, Ülfet Değer, Ayse Kevser Demir, İsmail Demir, Oğuzhan Sıtkı Dizdar, Erkan Dulkadiroğlu, Nur Düzen Oflas, Betül Erişmiş, Ali Erol, Ayşegül Ertınmaz, Müzeyyen Eryılmaz, Emin Gemcioğlu, Ahmed Bilal Genç, Melis Gökgöz, Nevzat Gözel, Fatih İleri, Kubilay İşsever, Uğur Can İzlimek, Özge Kama Başcı, Aynur Kamburoğlu, Fatih Kamış, Sanem Kayhan, İsmail Kırlı, Yusuf Kimyon, Şeref Enes Kocaman, Kamil Konur, Özge Kurtkulağı, Celalettin Küçük, Mehmet Selim Mamiş, Hatice Metin, Necip Nas, Sibel Ocak Serin, Oktay Olmuşçelik, Alihan Oral, Muhammet Özbilen, Erkan Özdemir, Ensar Özmen, Hikmet Öztop, Huseyin Ali Ozturk, Osman Özüdoğru, Emel Sağlam, Hatice Özge Serin, Hasan Sözel, Cem Şahin, Melisa Şahin Tekin, Enes Seyda Şahiner, Ahmet Veli Şanibaş, Yasin Şahintürk, Hakan Şıvgın, Abdullah Tanrıkulu, Tuba Taslamacıoğlu Duman, Gokhan Tazegul, Elif Duygu Topan, Hasan Tunca, Seyit Uyar, Ece Ünal Çetin, Nazif Yalçın, Demet Yalçın Kehribar, Selçuk Yaylacı, Mehmet Serdar Yıldırım, Hasan Esat Yıldırım, Hüseyin Yıldız, Pınar Yıldız, Hasan Esat Yücel, Oğuzhan Zengin, Ali Zeynettin, Fatih Atik, Selin Müge Aslan, Mert Akyıldız, Nurcan Aslan, Sare Babacan Çelikel, Suat Baran Bakan, Merve Durmuş, Mert Karacay, Çağatay Koçyiğitoğlu, Gökçe Paşa, Selvinaz Sivri, Tutku Naz Şahin, Yağmur Sena Tosun, Zeynep Gizem Totik, Rabia Ulutaş, Tuğçe Nur Yazıcı, Emrah Yılmaz, Hamit Yıldız, Alper Sönmez, Teoman Doğru. Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)Journal of Clinical Medicine 2025; 14(19): 7098 doi: 10.3390/jcm14197098
17
Akira Sasaki, Akira Umemura, Kazuyuki Ishida, Naoto Takahashi, Haruka Nikai, Hiroyuki Nitta, Yasuhiro Takikawa, Keisuke Kakisaka, Tamami Abe, Masao Nishiya, Tamotsu Sugai. The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical FeaturesBiomedicines 2022; 10(2): 453 doi: 10.3390/biomedicines10020453
18
Shweta Padher, Vinayak Walhekar, Ravindra Kulkarni, Varsha Pokharkar. Computational based in-silico and molecular docking approach for screening of phyto-constituents on PPAR targets in the treatment of NAFLDResearch Journal of Pharmacy and Technology 2025; : 232 doi: 10.52711/0974-360X.2025.00036
19
Tanmoy Mondal, Coleman I. Smith, Christopher A. Loffredo, Ruth Quartey, Gemeyel Moses, Charles D. Howell, Brent Korba, Bernard Kwabi-Addo, Gail Nunlee-Bland, Leanna R. Rucker, Jheannelle Johnson, Somiranjan Ghosh. Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †International Journal of Molecular Sciences 2023; 24(23): 16654 doi: 10.3390/ijms242316654
20
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz. Hígado graso (parte 2): enfoque clínico y tratamientoRevista colombiana de Gastroenterología 2023; 38(1): 46 doi: 10.22516/25007440.979
21
Giovanna McGinty, Robert Przemioslo. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implicationsWorld Journal of Gastroenterology 2024; 30(27): 3264-3267 doi: 10.3748/wjg.v30.i27.3264
22
Adnan Khan, Heather M. Ross, Natalia Salinas Parra, Sarah L. Chen, Kashyap Chauhan, Makala Wang, Brian Yan, John Magagna, Jake Beiriger, Yash Shah, Taha Shahzad, Dina Halegoua-DeMarzio. Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)Livers 2022; 2(4): 264 doi: 10.3390/livers2040022
23
Menooa Ebrahimi, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, Soghra Rabizadeh, Mojdeh Sarzaeim, Amirhossein Yadegar, Fatemeh Mohammadi, Razman Arabzadeh Bahri, Peyman Pakravan, Paria Shafiekhani, Manouchehr Nakhjavani, Alireza Esteghamati. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysisLipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01802-6
24
Juan Reyes-Barrera, Rosalinda Posadas-Sánchez, Gilberto Vargas-Alarcón, Guillermo C. Cardoso-Saldaña, Paloma Almeda-Valdes, Omar Yaxmehen Bello Chavolla, Luis Ortiz-Hernandez, Neftali Eduardo Antonio-Villa. MOFI-FL, a novel score for detecting hepatic steatosis and predicting cardiometabolic mortalityScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-15487-7
25
Jesse Pustjens, Willem P Brouwer, Ibrahim Ayada, Harry L A Janssen, Laurens A van Kleef. Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populationsWorld Journal of Gastroenterology 2025; 31(37): 107665 doi: 10.3748/wjg.v31.i37.107665